Bulk plasma and individual patient samples testing positive for CA15-3. CA15-3 is a biomedical marker used in the monitoring of treatment response in cancer patients. It is most widely used as a marker for breast cancer. Elevated CA15-3, in conjunction with alkaline phosphatasehase has been found to be associated with an increased chance of early recurrence of breast cancer.
| Abbreviation | CA15-3 |
| Variant Name | Product Code | Purity | |
|---|---|---|---|
+ |
CA15-3 Positive Serum/Plasma | SH164 | Positive |